Nephros Inc. (NASDAQ:NEPH) Short Interest Up 28.8% in March

Nephros Inc. (NASDAQ:NEPH) saw a significant growth in short interest in March. As of March 13th, there was short interest totaling 5,414 shares, a growth of 28.8% from the February 26th total of 4,205 shares. Currently, 0.1% of the company’s stock are sold short. Based on an average trading volume of 35,028 shares, the days-to-cover ratio is currently 0.2 days.

Hedge Funds Weigh In On Nephros

Several institutional investors and hedge funds have recently made changes to their positions in the business. XTX Topco Ltd grew its position in shares of Nephros by 48.5% during the fourth quarter. XTX Topco Ltd now owns 21,617 shares of the company’s stock worth $105,000 after buying an additional 7,062 shares in the last quarter. Quadrature Capital Ltd acquired a new stake in Nephros in the fourth quarter valued at $112,000. Kestra Advisory Services LLC bought a new position in Nephros during the 4th quarter valued at $29,000. Marshall Wace LLP acquired a new position in Nephros during the 4th quarter worth $107,000. Finally, Essex Investment Management Co. LLC grew its holdings in Nephros by 57.1% during the 4th quarter. Essex Investment Management Co. LLC now owns 38,984 shares of the company’s stock worth $190,000 after acquiring an additional 14,162 shares in the last quarter. 41.10% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Nephros in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $6.00.

Nephros Stock Performance

Shares of NASDAQ NEPH opened at $2.89 on Monday. Nephros has a 1 year low of $1.64 and a 1 year high of $6.42. The firm has a market cap of $30.75 million, a price-to-earnings ratio of 26.28 and a beta of 1.42. The stock’s 50-day simple moving average is $3.88 and its 200-day simple moving average is $4.57.

Nephros (NASDAQ:NEPH) last issued its quarterly earnings results on Thursday, March 12th. The company reported $0.01 EPS for the quarter, meeting analysts’ consensus estimates of $0.01. Nephros had a return on equity of 12.22% and a net margin of 6.35%.The firm had revenue of $4.73 million during the quarter, compared to the consensus estimate of $4.45 million.

Nephros Company Profile

Nephros, Inc is a development-stage company specializing in advanced water filtration and purification technologies for medical, laboratory, industrial and defense applications. The company’s core offering centers on proprietary hollow fiber ultrafilters designed to remove bacteria, viruses, endotoxins and particulates from water streams. These ultrafilters are used in hemodialysis systems to protect patient treatment, in pharmaceutical and laboratory environments to ensure water quality and in critical field-deployable units for military and emergency response.

The company’s product portfolio includes standalone filtration cartridges for point-of-use and point-of-entry installations in dialysis clinics and hospitals, as well as bench-top and portable water purification systems.